|
DSG2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.284100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.271800E-01 |
| Normal-vs-Stage2 |
2.816800E-01 |
| Normal-vs-Stage3 |
1.25689999519452E-08 |
| Normal-vs-Stage4 |
2.96269999644494E-08 |
| Stage1-vs-Stage2 |
2.764000E-01 |
| Stage1-vs-Stage3 |
7.08780000024944E-07 |
| Stage1-vs-Stage4 |
7.71710000013748E-07 |
| Stage2-vs-Stage3 |
1.560190E-02 |
| Stage2-vs-Stage4 |
1.286410E-02 |
| Stage3-vs-Stage4 |
7.710800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.882400E-02 |
| Normal-vs-AfricanAmerican |
4.975800E-02 |
| Normal-vs-Asian |
7.602200E-01 |
| Caucasian-vs-AfricanAmerican |
5.387200E-01 |
| Caucasian-vs-Asian |
8.904400E-01 |
| AfricanAmerican-vs-Asian |
6.292400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.050190E-01 |
| Normal-vs-Female |
4.389600E-02 |
| Male-vs-Female |
7.071400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.596440E-01 |
| Normal-vs-Age(41-60Yrs) |
6.644800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.321110E-03 |
| Normal-vs-Age(81-100Yrs) |
5.279200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.326200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.511800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.232600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.643600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.419800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.427600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.562800E-01 |
| Normal-vs-Grade 2 |
7.836600E-01 |
| Normal-vs-Grade 3 |
1.261430E-03 |
| Normal-vs-Grade 4 |
1.62492241884138E-12 |
| Grade 1-vs-Grade 2 |
8.350800E-01 |
| Grade 1-vs-Grade 3 |
2.347800E-01 |
| Grade 1-vs-Grade 4 |
3.324000E-03 |
| Grade 2-vs-Grade 3 |
1.458390E-02 |
| Grade 2-vs-Grade 4 |
4.08972855581169E-12 |
| Grade 3-vs-Grade 4 |
6.98220000039385E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.474400E-01 |
| Normal-vs-ccB subtype |
5.645000E-01 |
| ccA subtype-vs-ccB subtype |
8.361000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.440600E-01 |
| Normal-vs-N1 |
1.162020E-01 |
| N0-vs-N1 |
3.124600E-01 |
|
|
